?:authorAffiliation
|
-
[\'Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.\', \'Jiangsu Recbio Technology Co., Ltd., Taizhou, China.\', \'Beijing Advanced Innovation Center for Genomics (ICG) & Biomedical Pioneering Innovation Center (BIOPIC), Peking University; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China.\', \'Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.\', \'Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China.\', \'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. xuwb@ivdc.chinacdc.cn.\', \'Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China. huangweijin@nifdc.org.cn.\', \'Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China. wangyc@nifdc.org.cn.\']
|